文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

重症超声联合小剂量液体负荷试验评估脓毒性休克患者的容量反应性

[Evaluation of fluid responsiveness in patients with septic shock by critical ultrasound with small dose fluid challenge].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2022-01-01
一句话结论重症超声评估的小剂量液体负荷试验(100 mL/1 min)在脓毒性休克患者中可降低心率、中心静脉压,升高平均动脉压与VTI,并缩短ICU住院时间、机械通气时间及尿量达标时间。

该研究纳入2021年1月至12月大同市第三人民医院收治的36例脓毒性休克患者,随机分为对照组(传统液体负荷试验:30分钟内输注500 mL晶体液)与观察组(小剂量液体负荷试验:1分钟内输注100 mL晶体液),每组18例。采用重症超声测量血流动力学指标[中心静脉压(CVP)、有创平均动脉压(MAP)、速度时间积分(VTI)]及双侧肺超声评分,并观察结局指标。结果显示,观察组负荷后心率、CVP显著低于对照组,有创MAP、VTI显著高于对照组(均P<0.05);观察组超声评分显著优于对照组(均P<0.05)。观察组ICU住院时间、机械通气时间、尿量>0.5 mL×kg⁻¹×h⁻¹达标时间均显著短于对照组,去甲肾上腺素用量及复苏晶体液量显著少于对照组(均P<0.05)。相关性分析显示,晶体液量与M-BLUE肺超声(2、4、5区)、机械通气时间、去甲肾上腺素剂量、尿量达标时间及ΔVTI均高度一致(均P<0.05)。结论认为,重症超声评估的小剂量液体负荷试验对脓毒性休克患者容量反应性有较高评估价值,可降低液体过负荷导致明显组织水肿、器官损伤甚至危及生命的风风险,使液体负荷试验更合理恰当,从而提高治疗成功率。

要点

  • 小剂量液体负荷试验为1分钟内输注100 mL晶体液,传统液体负荷试验为30分钟内输注500 mL晶体液。
  • 负荷后观察组心率99.74±3.22次/min vs 对照组107.65±3.14次/min,CVP 7.55±0.22 mmHg vs 10.26±0.52 mmHg,均P<0.05。
  • 负荷后观察组有创MAP 77.36±2.14 mmHg vs 对照组69.81±2.56 mmHg,VTI 68.85±1.26 cm/s vs 44.71±1.28 cm/s,均P<0.05。
  • 观察组ICU住院时间138.26±1.25 h vs 对照组205.73±1.26 h,机械通气时间36.80±0.25 h vs 47.65±0.36 h,尿量>0.5 mL×kg⁻¹×h⁻¹达标时间27.38±1.25 h vs 38.61±1.30 h,均P<0.05。
  • 观察组去甲肾上腺素用量45.26±1.85 mg vs 对照组53.73±1.92 mg,复苏晶体液量1532.62±12.38 mL vs 1755.52±12.30 mL,均P<0.05。

适用人群与场景

  • 2021年1月至12月大同市第三人民医院收治的脓毒性休克患者36例,随机分为对照组和观察组,每组18例。

处置流程与药物剂量

  • 对照组:传统液体负荷试验,30分钟内输注500 mL晶体液。
  • 观察组:小剂量液体负荷试验,1分钟内输注100 mL晶体液。
  • 两组均采用重症超声测量血流动力学指标[中心静脉压(CVP)、有创平均动脉压(MAP)、速度时间积分(VTI)]及双侧肺超声评分。

研究设计与关键结果

  • 研究类型为随机对照研究,纳入36例脓毒性休克患者,每组18例;观察组采用小剂量液体负荷试验(100 mL晶体液/1分钟),对照组采用传统液体负荷试验(500 mL晶体液/30分钟)。
  • 负荷后观察组心率(99.74±3.22次/min vs 107.65±3.14次/min)和CVP(7.55±0.22 mmHg vs 10.26±0.52 mmHg)显著低于对照组,均P<0.05。
  • 负荷后观察组有创MAP(77.36±2.14 mmHg vs 69.81±2.56 mmHg)和VTI(68.85±1.26 cm/s vs 44.71±1.28 cm/s)显著高于对照组,均P<0.05。
  • 观察组超声评分显著优于对照组(均P<0.05)。
  • 观察组ICU住院时间(138.26±1.25 h vs 205.73±1.26 h)、机械通气时间(36.80±0.25 h vs 47.65±0.36 h)和尿量>0.5 mL×kg⁻¹×h⁻¹达标时间(27.38±1.25 h vs 38.61±1.30 h)均显著短于对照组,均P<0.05。
  • 观察组去甲肾上腺素用量(45.26±1.85 mg vs 53.73±1.92 mg)和复苏晶体液量(1532.62±12.38 mL vs 1755.52±12.30 mL)均显著少于对照组,均P<0.05。
  • 相关性分析显示,晶体液量与M-BLUE肺超声(2、4、5区)、机械通气时间、去甲肾上腺素剂量、尿量达标时间及ΔVTI均高度一致(均P<0.05)。

证据类型、等级与局限

  • 证据类型:随机对照研究(每组18例)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,重症超声评估的小剂量液体负荷试验对脓毒性休克患者容量反应性有较高评估价值,可降低液体过负荷导致明显组织水肿、器官损伤甚至危及生命的风风险,使液体负荷试验更合理恰当,从而提高治疗成功率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the value of critical ultrasound in evaluating the fluid responsiveness of small dose volume challenge in patients with septic shock.

METHODS: Thirty-six patients with septic shock admitted to the Third People's Hospital of Datong from January 2021 to December 2021 were enrolled, and the patients were randomly divided into control group and observation group, with 18 patients in each group. The control group was treated with traditional fluid challenge (500 mL of crystalloid injected within 30 minutes); the observation group received a small dose fluid challenge (100 mL of crystalloid injected within 1 minute). The hemodynamic indexes [central venous pressure (CVP), invasive mean arterial pressure (MAP), velocity-time integra (VTI)] and bilateral lung ultrasound scores were measured by critical ultrasound in both groups. The outcome related indicators of patients in the two groups were observed. The correlation between the above indexes and the fluid challenge was evaluated.

RESULTS: Compared with the control group, the heart rate (HR) and CVP of patients in the observation group after the challenge were significantly lower than those in the control group [HR (times/min): 99.74±3.22 vs. 107.65±3.14, CVP (mmHg, 1 mmHg ≈ 0.133 kPa): 7.55±0.22 vs. 10.26±0.52, both P < 0.05], invasive MAP and VTI were significantly higher than those in the control group [invasive MAP (mmHg): 77.36±2.14 vs. 69.81±2.56, VTI (cm/s): 68.85±1.26 vs. 44.71±1.28, both P < 0.05]. The ultrasonic score of the observation group was significantly better than those of the control group (all P < 0.05). In terms of outcome, the length of intensive care unit (ICU) stay, mechanical ventilation time and the time for urine volume more than 0.5 mL×kg-1×h-1 of the observation group were significantly shorter than those in the control group [the length of ICU stay (hours): 138.26±1.25 vs. 205.73±1.26, mechanical ventilation time (hours): 36.80±0.25 vs. 47.65±0.36, time to reach urine volume more than 0.5 mL×kg-1×h-1 (hours): 27.38±1.25 vs. 38.61±1.30, all P < 0.05], The dosage of norepinephrine was significantly decreased in the observation group compared with the control group (mg: 45.26±1.85 vs. 53.73±1.92, P < 0.05), and the amount of resuscitation crystalloid was significantly reduced compared with the control group (mL: 1 532.62±12.38 vs. 1 755.52 ± 12.30, P < 0.05). Correlation analysis showed that the volume of crystalloid was highly consistent with M-BLUE pulmonary ultrasound (zone 2, 4 and 5), mechanical ventilation time, norepinephrine dose, time to reach the standard of urine volume and ΔVTI (all P < 0.05).

CONCLUSIONS: Small dose fluid challenge evaluated by critical ultrasound in septic shock patients has a high value for fluid responsiveness, which can better reduce the risk of obvious tissue edema caused by fluid overload, organ damage and even life-threatening, make fluid challenge more reasonable and appropriate, thereby improving the success of treatment.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Yang J, Hou P, Yang Y, et al. [Evaluation of fluid responsiveness in patients with septic shock by critical ultrasound with small dose fluid challenge]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 36567589. doi:10.3760/cma.j.cn121430-20220627-00607

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。